This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.
0
Mappings
0
Definitions
0
Inheritance
3
Pathophysiology
0
Histopathology
6
Phenotypes
2
Genes
3
Treatments
4
Subtypes
0
Differentials
0
Datasets
0
Trials

Subtypes

4
Pulmonary Sarcoidosis
Most common form, affecting lungs and hilar lymph nodes; staged by chest radiograph findings.
Cardiac Sarcoidosis
Myocardial granulomas causing conduction abnormalities, heart failure, or sudden death.
Neurosarcoidosis
CNS involvement causing cranial neuropathies, meningitis, or mass lesions.
Cutaneous Sarcoidosis
Skin manifestations including erythema nodosum, lupus pernio, and papular lesions.

Pathophysiology

3
Granuloma Formation
Non-caseating granulomas consist of organized collections of activated macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells. Th1/Th17 immune responses drive granuloma development in response to unidentified antigens.
epithelioid macrophage link CD4-positive helper T cell link
granuloma formation link
Show evidence (1 reference)
PMID:35011621 PARTIAL
"Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas"
This review confirms the characteristic non-caseating granuloma formation in sarcoidosis.
Dysregulated Immune Response
Exaggerated CD4+ T helper cell response with Th1 polarization leads to interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction contributes to persistent inflammation. Paradoxical peripheral anergy coexists with organ-specific hyperactivity.
CD4-positive helper T cell link
inflammatory response link
Show evidence (1 reference)
PMID:35011621 PARTIAL
"Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease."
Review describes the multisystem inflammatory nature of sarcoidosis affecting multiple organs.
Fibrosis
Chronic granulomatous inflammation can progress to fibrosis, particularly in the lungs. Fibroblast activation and excessive collagen deposition lead to irreversible organ damage and functional impairment.

Phenotypes

6
Cardiovascular 1
Mediastinal Lymphadenopathy VERY_FREQUENT Mediastinal lymphadenopathy (HP:0100721)
Eye 1
Uveitis OCCASIONAL Uveitis (HP:0000554)
Immune 1
Erythema Nodosum OCCASIONAL Erythema nodosum (HP:0012219)
Respiratory 2
Dyspnea FREQUENT Dyspnea (HP:0002094)
Nonproductive Cough FREQUENT Nonproductive cough (HP:0031246)
Constitutional 1
Fatigue VERY_FREQUENT Fatigue (HP:0012378)
🧬

Genetic Associations

2
HLA-DRB1 Variants (Susceptibility)
BTNL2 Variants (Susceptibility)
💊

Treatments

3
Corticosteroid Therapy MAXO:0000640
First-line treatment for symptomatic sarcoidosis. Prednisone typically initiated at 20-40mg daily with gradual taper over months. Effective for most organ manifestations.
Methotrexate MAXO:0000058
Drug: methotrexate
Most commonly used steroid-sparing agent for chronic sarcoidosis. Allows reduction of corticosteroid dose while maintaining disease control.
Anti-TNF Therapy MAXO:0000058
Infliximab or adalimumab for refractory disease, particularly effective in neurosarcoidosis, lupus pernio, and cardiac sarcoidosis.
🌍

Environmental Factors

2
Occupational Exposures
Increased risk with exposure to insecticides, mold, and certain industrial dusts
Infectious Triggers
Mycobacterial and propionibacterial antigens have been implicated as potential triggers
🔬

Biochemical Markers

3
Elevated ACE (Elevated)
Context: Serum angiotensin-converting enzyme often elevated but not specific for diagnosis
Hypercalcemia (Elevated)
Context: Due to ectopic 1,25-dihydroxyvitamin D (calcitriol) production by granuloma macrophages
Elevated Inflammatory Markers (Elevated)
Context: ESR and CRP may be elevated during active disease
{ }

Source YAML

click to show
name: Sarcoidosis
creation_date: '2026-01-13T07:11:10Z'
updated_date: '2026-02-27T21:53:03Z'
category: Immune
description: >
  Sarcoidosis is a multisystem inflammatory disease of unknown etiology characterized
  by the formation of non-caseating granulomas, most commonly affecting the lungs
  and lymph nodes. It predominantly affects adults aged 20-40 years, with higher
  incidence in African Americans and Northern Europeans. Clinical presentation
  ranges from asymptomatic to severe organ dysfunction. While many cases resolve
  spontaneously, chronic progressive disease occurs in a significant subset.
disease_term:
  preferred_term: sarcoidosis
  term:
    id: MONDO:0019338
    label: sarcoidosis
parents:
- Granulomatous Disease
- Immune-Mediated Disease
has_subtypes:
- name: Pulmonary Sarcoidosis
  description: Most common form, affecting lungs and hilar lymph nodes; staged by chest radiograph findings.
- name: Cardiac Sarcoidosis
  description: Myocardial granulomas causing conduction abnormalities, heart failure, or sudden death.
- name: Neurosarcoidosis
  description: CNS involvement causing cranial neuropathies, meningitis, or mass lesions.
- name: Cutaneous Sarcoidosis
  description: Skin manifestations including erythema nodosum, lupus pernio, and papular lesions.
pathophysiology:
- name: Granuloma Formation
  description: >
    Non-caseating granulomas consist of organized collections of activated
    macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells.
    Th1/Th17 immune responses drive granuloma development in response to
    unidentified antigens.
  evidence:
  - reference: PMID:35011621
    supports: PARTIAL
    snippet: "Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas"
    explanation: "This review confirms the characteristic non-caseating granuloma formation in sarcoidosis."
  cell_types:
  - preferred_term: epithelioid macrophage
    term:
      id: CL:0002150
      label: epithelioid macrophage
  - preferred_term: CD4-positive helper T cell
    term:
      id: CL:0000492
      label: CD4-positive helper T cell
  biological_processes:
  - preferred_term: granuloma formation
    term:
      id: GO:0002432
      label: granuloma formation
- name: Dysregulated Immune Response
  description: >
    Exaggerated CD4+ T helper cell response with Th1 polarization leads to
    interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction
    contributes to persistent inflammation. Paradoxical peripheral anergy
    coexists with organ-specific hyperactivity.
  evidence:
  - reference: PMID:35011621
    supports: PARTIAL
    snippet: "Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease."
    explanation: "Review describes the multisystem inflammatory nature of sarcoidosis affecting multiple organs."
  cell_types:
  - preferred_term: CD4-positive helper T cell
    term:
      id: CL:0000492
      label: CD4-positive helper T cell
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
- name: Fibrosis
  description: >
    Chronic granulomatous inflammation can progress to fibrosis, particularly
    in the lungs. Fibroblast activation and excessive collagen deposition
    lead to irreversible organ damage and functional impairment.
phenotypes:
- name: Mediastinal Lymphadenopathy
  category: Pulmonary
  frequency: VERY_FREQUENT
  description: Symmetric enlargement of hilar and mediastinal lymph nodes, often the presenting finding on chest radiograph.
  phenotype_term:
    preferred_term: Mediastinal lymphadenopathy
    term:
      id: HP:0100721
      label: Mediastinal lymphadenopathy
- name: Dyspnea
  category: Pulmonary
  frequency: FREQUENT
  description: Shortness of breath due to pulmonary involvement and reduced lung function.
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
- name: Nonproductive Cough
  category: Pulmonary
  frequency: FREQUENT
  description: Dry, non-productive cough from airway and parenchymal inflammation.
  phenotype_term:
    preferred_term: Nonproductive cough
    term:
      id: HP:0031246
      label: Nonproductive cough
- name: Fatigue
  category: Constitutional
  frequency: VERY_FREQUENT
  description: Chronic fatigue is one of the most debilitating symptoms, often persisting after disease resolution.
  phenotype_term:
    preferred_term: Fatigue
    term:
      id: HP:0012378
      label: Fatigue
- name: Erythema Nodosum
  category: Dermatologic
  frequency: OCCASIONAL
  description: Painful red nodules on the shins, often associated with acute sarcoidosis (Lofgren syndrome).
  phenotype_term:
    preferred_term: Erythema nodosum
    term:
      id: HP:0012219
      label: Erythema nodosum
- name: Uveitis
  category: Ophthalmologic
  frequency: OCCASIONAL
  description: Eye inflammation that can lead to vision impairment if untreated. May be anterior, posterior, or panuveitis.
  phenotype_term:
    preferred_term: Uveitis
    term:
      id: HP:0000554
      label: Uveitis
biochemical:
- name: Elevated ACE
  presence: Elevated
  context: Serum angiotensin-converting enzyme often elevated but not specific for diagnosis
- name: Hypercalcemia
  presence: Elevated
  context: Due to ectopic 1,25-dihydroxyvitamin D (calcitriol) production by granuloma macrophages
- name: Elevated Inflammatory Markers
  presence: Elevated
  context: ESR and CRP may be elevated during active disease
genetic:
- name: HLA-DRB1 Variants
  association: Susceptibility
  notes: HLA-DRB1*03 associated with acute, self-limited disease; HLA-DRB1*15 with chronic disease
- name: BTNL2 Variants
  association: Susceptibility
  notes: Butyrophilin-like 2 gene variants increase sarcoidosis risk
environmental:
- name: Occupational Exposures
  notes: Increased risk with exposure to insecticides, mold, and certain industrial dusts
- name: Infectious Triggers
  notes: Mycobacterial and propionibacterial antigens have been implicated as potential triggers
treatments:
- name: Corticosteroid Therapy
  description: >
    First-line treatment for symptomatic sarcoidosis. Prednisone typically
    initiated at 20-40mg daily with gradual taper over months. Effective
    for most organ manifestations.
  treatment_term:
    preferred_term: corticosteroid agent therapy
    term:
      id: MAXO:0000640
      label: corticosteroid agent therapy
- name: Methotrexate
  description: >
    Most commonly used steroid-sparing agent for chronic sarcoidosis.
    Allows reduction of corticosteroid dose while maintaining disease control.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
    therapeutic_agent:
    - preferred_term: methotrexate
      term:
        id: CHEBI:44185
        label: methotrexate
- name: Anti-TNF Therapy
  description: >
    Infliximab or adalimumab for refractory disease, particularly effective
    in neurosarcoidosis, lupus pernio, and cardiac sarcoidosis.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
datasets: